World's Best Scientists 2026 revealed!

D-Index & Metrics

Chemistry

D-Index
64
Citations
17744
World Ranking
7947
National Ranking
2308

Peter A. Crooks publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Peter A. Crooks sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 715 publications — 96th percentile

96% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Peter A. Crooks D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Peter A. Crooks sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 64 D-Index — 56th percentile

56% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Research.com Recognitions

  • 2016 - Fellow, National Academy of Inventors

Overview

Peter A. Crooks is affiliated with the University of Arkansas for Medical Sciences in the United States. Their research spans the fields of Biochemistry, Genetics, and Molecular Biology, as well as Medicine, with a focused concentration in Molecular Biology, Physiology, Cellular and Molecular Neuroscience, Pharmacology, and Cancer Research.

The scientist's work covers several main topics including DNA Repair Mechanisms, RNA modifications and cancer, Alzheimer's disease research and treatments, Neuroscience and Neuropharmacology Research, Computational Drug Discovery Methods, Cholinesterase and Neurodegenerative Diseases, and Nicotinic Acetylcholine Receptors Study.

Recent scientific publications by Peter A. Crooks include:

  • Structural modeling of GSK3β implicates the inactive (DFG-out) conformation as the target bound by TDZD analogs (2020), Scientific Reports
  • Design and Synthesis of Novel Hybrid 8-Hydroxy Quinoline-Indole Derivatives as Inhibitors of Aβ Self-Aggregation and Metal Chelation-Induced Aβ Aggregation (2020), Molecules
  • Biobanked Glioblastoma Patient-Derived Organoids as a Precision Medicine Model to Study Inhibition of Invasion (2021), International Journal of Molecular Sciences
  • Novel hydroxybenzylamine-deoxyvasicinone hybrids as anticholinesterase therapeutics for Alzheimer's disease (2021), Bioorganic & Medicinal Chemistry
  • Binding Modes and Selectivity of Cannabinoid 1 (CB1) and Cannabinoid 2 (CB2) Receptor Ligands (2020), ACS Chemical Neuroscience

Frequent publication venues for this researcher include:

  • Scientific Reports (2 publications)
  • Molecules (2 publications)
  • Bioorganic & Medicinal Chemistry (2 publications)
  • Frontiers in Pharmacology (2 publications)
  • International Journal of Molecular Sciences (1 publication)

Peter A. Crooks collaborates regularly with several co-authors, including:

  • Narsimha Reddy Penthala (12 joint publications)
  • Soma Shekar Dachavaram (6 joint publications)
  • Meenakshisundaram Balasubramaniam (4 joint publications)
  • Robert J. Shmookler Reis (4 joint publications)
  • Paul L. Prather (4 joint publications)

In recognition of contributions to their field, Peter A. Crooks was awarded the title of Fellow by the National Academy of Inventors in 2016.

Best Publications

  • Polynucleotide analogs containing sulfonate and sulfonamide internucleoside linkages

    Joseph A. Maddry;Robert C. Reynolds;John A. Secrist;John A. Montgomery

  • High performance liquid chromatographic analysis of the pharmacologically active quinones and related compounds in the oil of the black seed (Nigella sativa L.)

    Omar A. Ghosheh;Abdulghani A. Houdi;Peter A. Crooks

  • An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells

    Monica L. Guzman;Randall M. Rossi;Sundar Neelakantan;Xiaojie Li

  • Means to achieve sustained release of synergistic drugs by conjugation

    Paul Ashton;Peter Anthony Crooks;Tadeusz Cynkowski;Grazyna Cynkowska

  • A novel mechanism of action and potential use for lobeline as a treatment for psychostimulant abuse.

    Linda P. Dwoskin;Peter A. Crooks

  • Molecular pathway for thymoquinone-induced cell-cycle arrest and apoptosis in neoplastic keratinocytes.

    Hala U Gali-Muhtasib;Wassim G Abou Kheir;Lynn A Kheir;Nadine Darwiche

  • Aminoparthenolides as novel anti-leukemic agents: Discovery of the NF-kappaB inhibitor, DMAPT (LC-1).

    Sundar Neelakantan;Shama Nasim;Monica L. Guzman;Craig T. Jordan

  • Targeting Aberrant Glutathione Metabolism to Eradicate Human Acute Myelogenous Leukemia Cells

    Shanshan Pei;Mohammad Minhajuddin;Kevin P. Callahan;Marlene Balys

  • A NADPH Oxidase–Dependent Redox Signaling Pathway Mediates the Selective Radiosensitization Effect of Parthenolide in Prostate Cancer Cells

    Yulan Sun;Daret K. St. Clair;Yong Xu;Peter A. Crooks

  • Lobeline attenuates d-methamphetamine self-administration in rats.

    Steven B. Harrod;Linda P. Dwoskin;Peter A. Crooks;Jennifer E. Klebaur

  • Lobeline and nicotine evoke [3H]overflow from rat striatal slices preloaded with [3H]dopamine: differential inhibition of synaptosomal and vesicular [3H]dopamine uptake.

    Lihong Teng;Peter A. Crooks;Patricia K. Sonsalla;Linda P. Dwoskin

  • Competitive Neuronal Nicotinic Receptor Antagonists: A New Direction for Drug Discovery

    Linda P. Dwoskin;Peter A. Crooks

  • Unexpected pehnomenon in the high-performance liquid chromatographic anlaysis of racemic 14C-labelled nicotine: Separation of enantiomers in a totally achiral system

    K.C. Cundy;P.A. Crooks

  • Stereochemical course of the transmethylation catalyzed by catechol O-methyltransferase.

    R W Woodard;M D Tsai;H G Floss;P A Crooks

  • Vesicular monoamine transporter 2: role as a novel target for drug development.

    Guangrong Zheng;Linda P. Dwoskin;Peter A. Crooks

  • Cellulose sulfuric acid: An efficient biodegradable and recyclable solid acid catalyst for the one-pot synthesis of aryl-14H-dibenzo[a.j]xanthenes under solvent-free conditions

    J. Venu Madhav;Y. Thirupathi Reddy;P. Narsimha Reddy;M. Nikhil Reddy

  • Nornicotine is self-administered intravenously by rats

    M. T. Bardo;Thomas Green;P. A. Crooks;L. P. Dwoskin

  • (S)-(-)-Cotinine, the major brain metabolite of nicotine, stimulates nicotinic receptors to evoke [3H]dopamine release from rat striatal slices in a calcium-dependent manner.

    Linda P. Dwoskin;Lihong Teng;Susan T. Buxton;Peter A. Crooks

  • Lobeline Inhibits the Neurochemical and Behavioral Effects of Amphetamine

    Dennis K. Miller;Peter A. Crooks;Lihong Teng;Jeffrey M. Witkin

  • Contribution of CNS Nicotine Metabolites to the Neuropharmacological Effects of Nicotine and Tobacco Smoking

    Peter A. Crooks;Linda P. Dwoskin

  • Aminoparthenolides as Novel anti‐Leukemic Agents: Discovery of the NF‐ϰB Inhibitor, DMAPT (LC‐1).

    Sundar Neelakantan;Shama Nasim;Monica L. Guzman;Craig T. Jordan

Frequent Co-Authors

Linda P. Dwoskin
Linda P. Dwoskin University of Kentucky
Sean Parkin
Sean Parkin University of Kentucky
Michael T. Bardo
Michael T. Bardo University of Kentucky
Craig T. Jordan
Craig T. Jordan University of Colorado Anschutz Medical Campus
Michael L. Freeman
Michael L. Freeman Vanderbilt University Medical Center
Harikrishna Nakshatri
Harikrishna Nakshatri Indiana University
Christopher Sweeney
Christopher Sweeney Harvard University
J. Michael McIntosh
J. Michael McIntosh University of Utah
Roger L. Papke
Roger L. Papke University of Florida
Chang-Guo Zhan
Chang-Guo Zhan University of Kentucky

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Chemistry in the USA opens doors to various related online degrees and career pathways that complement scientific expertise. For those interested in the legal side of science, obtaining a 2 year criminal justice degree online can provide foundational knowledge applicable in regulatory compliance or environmental law.

Another valuable option is pursuing paralegal studies. Understanding the paralegal salary and job market can help students assess if supporting legal processes in a scientific context suits their goals. This path complements analytical skills developed through chemistry coursework.

For those interested in the pharmaceutical industry, careers like pharmaceutical sales offer a dynamic alternative. Learning about the pharma sales rep salary and the necessary skills provides insight into how science graduates can leverage their knowledge in business roles.

Finally, becoming a licensed pharmacist remains a high-demand science career. However, prospective students should consider whether is it hard to become a pharmacist fits their commitment level, as the path requires significant education and training but offers rewarding professional opportunities.

Best Scientists Citing Peter A. Crooks

Trending Scientists

Recently Published Articles